In the Boardroom
Refine Search
Pharmaceutical
UK-based NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announced the appointment of Michael Shih as chief executive (CEO) and to the board of directors, effective immediately. 16 December 2024
Pharmaceutical
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief medical officer (CMO) and will become a member of Gilead’s senior leadership team. Dr Berger succeeds Dr Merdad Parsey. 13 December 2024
Pharmaceutical
AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while under investigation in China. 4 December 2024
Pharmaceutical
Bausch Health Bausch Health (NYSE/TSX: BHC) has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. 3 December 2024
Pharmaceutical
Germany’s Evotec has said its chief operating officer Craig Johnstone will leave the business at the end of the year. 29 November 2024
Pharmaceutical
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that Dr Thomas Schinecker, chief executive (CEO) of Swiss pharma giant Roche (ROG: SIX), will take up the post as president of the trade association effective January 1, 2025. 26 November 2024
Pharmaceutical
Specialist pre-clinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has announced the appointment of Lee Patterson as its new chief executive. 25 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Pharmaceutical
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Pharmaceutical
Following swiftly on yesterday’s news, KaloBios Pharmaceuticals announced that an investor group led by Martin Shkreli, the founder and chief executive of privately-held Turing Pharmaceuticals AG, has acquired 70% of its outstanding shares, up from 55% previously. 20 November 2015
Pharmaceutical
Belgian pharma major UCB has appointed Steve Turley as managing director for the UK and Ireland. 16 November 2015
Pharmaceutical
The UK division of Japanese pharma company Takeda has appointed two new directors in a bid to drive forward its expertise in the specialty care sector. 13 November 2015
Pharmaceutical
After 24 years’ service to Boehringer Ingelheim, Professor Andreas Barner will retire as chairman of the board of managing directors on June 30, 2016, and will move to the Shareholders' Committee of Boehringer Ingelheim, a family-owned German pharma major. 6 November 2015
Pharmaceutical
German pharma company Merck has appointed Laszlo Radvanyi as head of global immuno-oncology research. 2 November 2015
Pharmaceutical
Swiss drug company Roche has appointed Richard Erwin as the new UK general manager. 23 October 2015
Pharmaceutical
Sorrento Therapeutics has appointed Jeffrey Su as executive vice president and chief operating officer. 19 October 2015
Pharmaceutical
Merck KGaA has appointed Stefan Oschmann as chief executive and chairman of the executive board. 13 October 2015
Pharmaceutical
The European Medicines Agency’s management board has nominated Guido Rasi as the executive director of the Agency. At an extraordinary session on October 1, the board selected Prof Rasi from a shortlist of candidates provided by the European Commission. 1 October 2015
Pharmaceutical
Danish insulin giant Novo Nordisk has appointed Stephen Gough as senior principal clinical scientist. 30 September 2015
Pharmaceutical
Contract research and manufacturing organization Albany Molecular Research has made George Svokos chief operating officer, and Lori Henderson head of corporate business development. 14 September 2015
Pharmaceutical
Netherlands-based Pharming Group has appointed Robin Wright as chief financial officer. 10 September 2015
Pharmaceutical
Immune Pharmaceuticals has named Boris Shor as executive director for research and development (R&D) and scientific partnerships. 9 September 2015
Pharmaceutical
Duchenne muscular dystrophy (DMD) specialist Summit Therapeutics has appointed Ralf Rosskamp as chief medical officer. 2 September 2015
Pharmaceutical
Anglo-Swedish drug major AstraZeneca has appointed Sean Bohen as executive vice president of global medicines development and chief medical officer. 24 August 2015
Pharmaceutical
Germany’s Merck KGaA named Isabel De Paoli head of group communications effective March 9, 2016. She will succeed Walter Huber, who is set to retire in March next year. 30 July 2015
Pharmaceutical
Pharma giant Merck & Co on Tuesday said it has agreed to buy Israel-based drugmaker cCAM Biotherapeutics for as much as $605 million in a bid to expand its immuno-oncology portfolio. 29 July 2015
Pharmaceutical
Privately-held pharma company Otic, focused on ear, nose and throat disorders, has appointed Gregory Flesher as chief executive and member of the board. 27 July 2015
Pharmaceutical
Sanofi Pasteur MSD, the joint venture company between Sanofi and Merck, has appointed David Khougazian as president. 29 June 2015
Pharmaceutical
UK developer of inhaled therapies Vectura has appointed James Ward-Lilley as chief executive and executive director. 24 June 2015
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze